This research focuses on the development of radioactive probes and imaging techniques which optimise the assessment of a functional status of a disease, and to tailor radio-ligands that enable the best therapeutic plan for patients.
The use of radiolabelled probes to improve health currently has two components:
Follow up of disease progression and therapy benefits
Help to adjust therapeutic strategy for each patient (personalised medicine)
There are three main directions for research:
To develop novel radiochemistry methodology and radiolabelling techniques to improve radiolabelling efficiencies, and to decrease radiolabelling time via macro and microfluidic and microwave technologies
To develop novel radioligands (small molecules, peptides, proteins, cells or particles) for imaging (PET, SPECT) and targeted radioisotope therapy
To optimise imaging and quantification techniques for new radio-isotopes and various organs of interest